Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
- CheckMate 214 investigators
- Department of Medicine
- Memorial Sloan-Kettering Cancer Center
- Department of Hematology and Medical Oncology
- Cleveland Clinic Foundation
- Department of Hematology and Medical Oncology
- Dana-Farber Harvard Cancer Center
- Department of Medical Oncology
- Centro de Investigación Clínica Bradford Hill
- Department of Oncology and Urology
- Johns Hopkins University
- Department of Medical Oncology
- Fundación Arturo López Pérez
- Institut de Cancérologie Gustave Roussy
- KU Leuven
- Levine Cancer Institute
- Department of Medical Oncology
- IRCCS Fondazione Policlinico San Matteo - Pavia
- Department of Medicine
- Roswell Park Cancer Institute
- Department of Oncology
- Rabin Medical Center Israel
- Tel Aviv University
- Department of Oncology
- IRCCS Policlinico San Donato
- University of Washington
- Department of Medical Oncology
- University Hospital of Strasbourg
- Sheba Medical Center at Tel Hashomer
- Department of Hematology and Oncology
- Fox Chase Cancer Center
- Department of Medical Oncology
- University of Groningen
- Department of Internal Medicine
- University of Michigan, Ann Arbor
- Department of Oncology
- Palacký University Olomouc
- Department of Genitourinary Oncology
- Queen Mary University of London
- Department of Cancer Services: Oncology
- East and North Hertfordshire NHS Trust
- Department of Medical Oncology
- Hôpital Européen Georges Pompidou
- Department of Oncology
- Southern Health Familial Cancer Centre
- Department of Genitourinary Oncology
- Brigham and Women’s Hospital
- Harvard University
- Department of Oncology
- Aarhus University
- Department of Urology
- Friedrich Schiller University Jena
- Macquarie University
- Department of Oncology
- University of Calgary
- Department of Medicine
- Provincial Health Services Authority
- Division of Medical Oncology
- Duke University
- Department of Urology
- Niigata University
- Department of Medical Oncology
- Hospital Universitario Marques de Valdecilla
- Interdisciplinary Genitourinary Oncology at the West-German Cancer Center
- University of Duisburg-Essen
- Bristol-Myers Squibb
- Department of Genitourinary Medical Oncology
- University of Texas Health Science Center at Houston
Research output: Contribution to journal › Article › peer-review
708
Scopus
citations